跳至主要内容
临床试验/IRCT201208043799N5
IRCT201208043799N5已完成2 期

Effects of low dose colchicin in prevention of atrial fibrillation after coronary artery bypass graft (A Placebo-Controlled Randomized Clinical Trial)

Tehran University of Medical Sciences Vice chancellor for research0 个研究点目标入组 216 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
216

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 80 years(—)
性别
All

入选标准

  • Patients with coronary artery disease (on angiography) who are candidate for coronary artery bypass. Exclusion criteria: 1- Patients above 80 years old. 2- Patients who have atrial fibrillation before surgery. 3- Patients with heart valve disease or arrhythmia or having every degree of heart block conduction. 4- Patients who use a pacemaker. 5- Patients who have chronic lung, liver or kidney disease. 6- Patients who have other heart surgeries simultaneously with bypass surgery. 7- Patients who are allergic to colchicine or in any way giving colchicine to them is contraindicated. 8- Having sick sinus syndrome.

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Sciences Vice chancellor for research

相似试验